Diligence memo · auto-generated · as of July 2, 2026
Morphogenyx Inc
Morphogenyx Inc looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Morphogenyx Inc operates in Biotechnology, based in EAST NORTPORT.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Morphogenyx Inc has raised $4.0M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $1.0M on 2017-07-01.
Most recent recorded round closed around 2020-08-17.
Valuation (modeled)modeled
Provath models Morphogenyx Inc at approximately $51M (range $533K–$555M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 3.27× the median modeled value of Pre-Seed Biotechnology companies in 2019–2021 (156 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 13 months.
Last raise 5.9 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 1.0× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 40% of Biotechnology peers (4291 compared).
Modeled value ranks above 45% of those peers.
Closest niche peers: Pinpoint Therapeutics Inc., Crimson BioPharm Inc., Transplant Logistics & Informatics Llc, Pylum Biosciences, Inc., RNAissance AG LLC.
Peoplefiled
1 named person on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.